IDO1 Metabolites Activate β-catenin Signaling to Promote Cancer Cell Proliferation and Colon Tumorigenesis in Mice

Gastroenterology

Volumn 145, Issue 2, 2013, Pages

  Thaker, Ameet I ^a   Rao, M Suprada ^a   Bishnupuri, Kumar S ^a   Kerr, Thomas A ^a   Foster, Lynne ^a   Marinshaw, Jeffrey M ^a   Newberry, Rodney D ^a   Stenson, William F ^a   Ciorba, Matthew A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Mouse Model Metabolism Ulcerative Colitis IBD

Indexed keywords

BETA CATENIN; INDOLEAMINE 2,3 DIOXYGENASE; INDOLEAMINE 2,3 DIOXYGENASE 1; KYNURENINE; N METHYLTRYPTOPHAN; SMALL INTERFERING RNA; TRYPTOPHAN; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CELL PROLIFERATION; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; HISTOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTESTINE EPITHELIUM CELL; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR GROWTH; ULCERATIVE COLITIS;

EID: 84880630193     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.05.002     Document Type: Article

References (41)

1. D.H. Munn, and A.L. Mellor Indoleamine 2,3-dioxygenase and tumor-induced tolerance J Clin Invest 117 2007 1147 1154
2. G. Brandacher, A. Perathoner, and R. Ladurner Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells Clin Cancer Res 12 2006 1144 1151
3. Y.F. Gao, R.Q. Peng, and J. Li The paradoxical patterns of expression of indoleamine 2,3-dioxygenase in colon cancer J Transl Med 7 2009 71
4. L. Ferdinande, C. Decaestecker, and L. Verset Clinicopathological significance of indoleamine 2,3-dioxygenase 1 expression in colorectal cancer Br J Cancer 106 2012 141 147
5. M.A. Ciorba Indoleamine 2,3 dioxygenase in intestinal disease Curr Opin Gastroenterol 29 2013 146 152
6. L. Ferdinande, P. Demetter, and C. Perez-Novo Inflamed intestinal mucosa features a specific epithelial expression pattern of indoleamine 2,3-dioxygenase Int J Immunopathol Pharmacol 21 2008 289 295
7. B.K. Dieckgraefe, W.F. Stenson, and J.R. Korzenik Analysis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays Physiol Genomics 4 2000 1 11
8. J.J. Hansen, L. Holt, and R.B. Sartor Gene expression patterns in experimental colitis in IL-10-deficient mice Inflamm Bowel Dis 15 2009 890 899
9. M.A. Ciorba, E.E. Bettonville, and K.G. McDonald Induction of IDO-1 by immunostimulatory DNA limits severity of experimental colitis J Immunol 184 2010 3907 3916
10. A.M. Wolf, D. Wolf, and H. Rumpold Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease Clin Immunol 113 2004 47 55
11. N.K. Gupta, A.I. Thaker, and N. Kanuri Serum analysis of tryptophan catabolism pathway: correlation with Crohn's disease activity Inflamm Bowel Dis 18 2012 1214 1220
12. G.J. Gurtner, R.D. Newberry, and S.R. Schloemann Inhibition of indoleamine 2,3-dioxygenase augments trinitrobenzene sulfonic acid colitis in mice Gastroenterology 125 2003 1762 1773
13. G. Matteoli, E. Mazzini, and I.D. Iliev Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction Gut 59 2010 595 604
14. T.A. Ullman, and S.H. Itzkowitz Intestinal inflammation and cancer Gastroenterology 140 2011 1807 1816
15. J. Terzic, S. Grivennikov, and E. Karin Inflammation and colon cancer Gastroenterology 138 2010 2101-2114 e5
16. A.I. Thaker, A. Shaker, and M.S. Rao Modeling colitis-associated cancer with azoxymethane (AOM) and dextran sulfate sodium (DSS) J Vis Exp 67 2012 4100
17. A.I. Thaker, E.E. Bettonville, and W.F. Stenson Indoleamine-2,3- dioxygenase-1 exerts distinct non-T-cell mediated protective functions in acute colitis Gastroenterology 138 2010 S261:S1726
18. H.S. Cooper, S.N. Murthy, and R.S. Shah Clinicopathologic study of dextran sulfate sodium experimental murine colitis Lab Invest 69 1993 238 249
19. K. Katakura, J. Lee, and D. Rachmilewitz Toll-like receptor 9-induced type I IFN protects mice from experimental colitis J Clin Invest 115 2005 695 702
20. H.S. Cooper, S. Murthy, and K. Kido Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-associated neoplasia in the human: a study of histopathology, B-catenin and p53 expression and the role of inflammation Carcinogenesis 21 2000 757 768
21. M.A. Ciorba, T.E. Riehl, and M.S. Rao Lactobacillus probiotic protects intestinal epithelium from radiation injury in a TLR-2/cyclo-oxygenase-2- dependent manner Gut 61 2012 829 838
22. T.A. Kerr, M.A. Ciorba, and H. Matsumoto Dextran sodium sulfate inhibition of real-time polymerase chain reaction amplification: a poly-A purification solution Inflamm Bowel Dis 18 2012 344 348
23. A. Voronkov, and S. Krauss Wnt/beta-catenin signaling and small molecule inhibitors Curr Pharm Des 19 2013 634 664
24. E.H. Jho, T. Zhang, and C. Domon Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway Mol Cell Biol 22 2002 1172 1183
25. D.H. Munn, M.D. Sharma, and B. Baban GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase Immunity 22 2005 633 642
26. F. Fallarino, U. Grohmann, and C. Vacca T cell apoptosis by kynurenines Adv Exp Med Biol 527 2003 183 190
27. J. Ye, M. Kumanova, and L.S. Hart The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation EMBO J 29 2010 2082 2096
28. A.J. Muller, M.D. Sharma, and P.R. Chandler Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase Proc Natl Acad Sci U S A 105 2008 17073 17078
29. S.E. Baldus, S.P. Monig, and S. Huxel MUC1 and nuclear beta-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis Clin Cancer Res 10 2004 2790 2796
30. K. Ogawa, T. Hara, and M. Shimizu Suppression of azoxymethane-induced colonic preneoplastic lesions in rats by 1-methyltryptophan, an inhibitor of indoleamine 2,3-dioxygenase Cancer Sci 103 2012 951 958
31. X.C. He, T. Yin, and J.C. Grindley PTEN-deficient intestinal stem cells initiate intestinal polyposis Nat Genet 39 2007 189 198
32. G. Lee, T. Goretsky, and E. Managlia Phosphoinositide 3-kinase signaling mediates beta-catenin activation in intestinal epithelial stem and progenitor cells in colitis Gastroenterology 139 2010 869 881 881 e1-9
33. T.C. Ko, F. Pan, and H. Sheng Cyclin D3 is essential for intestinal epithelial cell proliferation World J Surg 26 2002 812 818
34. A. Mermelshtein, A. Gerson, and S. Walfisch Expression of D-type cyclins in colon cancer and in cell lines from colon carcinomas Br J Cancer 93 2005 338 345
35. H. Tanami, H. Tsuda, and S. Okabe Involvement of cyclin D3 in liver metastasis of colorectal cancer, revealed by genome-wide copy-number analysis Lab Invest 85 2005 1118 1129
36. C.A. Opitz, U.M. Litzenburger, and F. Sahm An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor Nature 478 2011 197 203
37. K. Kawajiri, Y. Kobayashi, and F. Ohtake Aryl hydrocarbon receptor suppresses intestinal carcinogenesis in ApcMin/+ mice with natural ligands Proc Natl Acad Sci U S A 106 2009 13481 13486
38. A. Garten, S. Petzold, and A. Korner Nampt: linking NAD biology, metabolism and cancer Trends Endocrinol Metab 20 2009 130 138
39. G.Y. Chen, and G. Nunez Inflammasomes in intestinal inflammation and cancer Gastroenterology 141 2011 1986 1999
40. M.Y. Chang, C. Smith, and J.B. Duhadaway Cardiac and gastrointestinal liabilities caused by deficiency in the immune modulatory enzyme indoleamine 2,3-dioxygenase Cancer Biol Ther 12 2011 1050 1058
41. J.B. Katz, A.J. Muller, and G.C. Prendergast Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape Immunol Rev 222 2008 206 221